Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.60    -0.05 (-1.08%)
Bid:
4.60
Ask:
4.70
Spread: 0.10 (2.174%)
Market Cap: £220.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director & Senior Manager Share Awards

28 Apr 2011 13:44

RNS Number : 6633F
Seeing Machines Limited
28 April 2011
 



28 April 2011

 

 

SEEING MACHINES LIMITED

 

DIRECTOR & Senior Manager SHARE AWARDS

Seeing Machines Limited (AIM:SEE), a leading developer of advanced computer based imaging software systems announces that it has today issued 767,099 new fully paid ordinary shares ("New Ordinary Shares") to certain Directors and senior managers under the July 2010 Executive Share Plan which was approved at the Annual General Meeting in November 2010. All shares issued under the plan are based on a salary/fee sacrifice arrangement.

Under the plan the Directors' received shares as follows:

Director

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Robert Charles Sale 1

120,724

5,487,808

1.34%

Nicholas John Cerneaz2

188,631

2,049,044

0.50%

David John Gaul 3

60,362

2,020,948

0.49%

Trent William Victor

60,362

236,236

0.06%

1. Robert Sales shares are 2,745,715 shares held in the name of Caffe Pty Ltd ATF the R C Sale Superannuation Fund, 2,621,369 shares held by Robert's wife Paula Kay Sale and 120,724 shares held in his own name.

2. Nicholas John Cerneaz holds 1,467,332 shares through Cenika Pty Ltd ATF Cenika Super Fund and 581,712 in his own name.

3. David Gaul holds 2,020,948 shares through his company Jaiclimb Pty Limited.

Under the Plan the following senior managers received shares as follows:

Senior Manager

Role

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Belinda Burgess 4

COO & Company Secretary

186,116

2,401,550

0.59%

Timothy Edwards

Principal Engineer

75,452

21,681,316

5.30%

Sebastien Rougeaux

Principal Research Scientist

75,452

22,174,792

5.42%

4. Belinda Burgess holds 965,870 shares in her own name and 1,435,680 shares in the names Belinda Burgess and Jennifer Kruse as trustees for the Meg & Susie Super Fund.

Application has been made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur and that dealings will commence at 8.00 a.m. on 6 May 2011. Immediately following admission of the New Ordinary Shares, the Company will have 408,908,546 fully paid ordinary shares on issue.

 

Enquiries:

 

Seeing Machines Limited

Nick Cerneaz, CEO +61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby +44 (0) 20 7776 6550

Walbrook PR Ltd

Bob Huxford +44 (0) 20 7933 8783

Helen Westaway +44 (0) 20 7933 8790

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDMGZDZRZGMZM
Date   Source Headline
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding
5th Apr 20239:08 amRNSPDMR Shareholding
31st Mar 202312:26 pmRNSPDMR Shareholding
29th Mar 202311:55 amRNSDirector/PDMR Shareholding
28th Mar 202311:28 amRNSPDMR Shareholding
27th Mar 202310:12 amRNSDirector/PDMR Shareholding
27th Mar 202310:07 amRNSDirector/PDMR Shareholding
24th Mar 202311:56 amRNSPDMR Shareholding
24th Mar 20238:59 amRNSDirector/PDMR Shareholding
22nd Mar 20239:16 amRNSPDMR Shareholding
17th Mar 20239:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.